A protracted lull following the flurry of mitral valve acquisitions by the big device companies in 2015 has been broken, this time with news that Edwards Lifesciences has acquired the Israel-based ...
Edwards Lifesciences is buying Valtech Cardio Ltd., which has developed the Cardioband System for transcatheter mitral and tricuspid valve repair. Valtech's Cardioband System is designed for minimally ...
HARRISBURG, PA, April 25, 2018 (GLOBE NEWSWIRE) -- The ACTIVE trial studies Edwards Cardioband Mitral Reconstruction System, a catheter-based annular reduction device for treatment of functional ...
IRVINE, Calif., Edwards Lifesciences Corporation, the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced that it has received CE ...
The 30-day outcomes from the TRISCEND study of the transfemoral EVOQUE tricuspid valve replacement system demonstrated technical feasibility and an acceptable safety profile, along with improvements ...
Transaction Provides Opportunity to Optimize the Significant Potential of the Cardioband[TM] Heart Valve Repair System Valtech Cardio, Ltd. [http://www.valtechcardio ...
IRVINE, Calif., Oct. 19, 2023 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW) today announced the company's EVOQUE tricuspid valve replacement system received CE Mark for the transcatheter ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results